$MLAB News

Mesa Labs (NASDAQ:MLAB) Delivers Mixed Q4 Results as EPS Surges Past Estimates but Revenue Falls Short

Mesa Laboratories Q4 Adj. EPS $3.30 Beats $0.34 Estimate, Sales $63.724M Miss $65.171M Estimate

Mesa Laboratories: Hard To Set The Right Diagnosis

Mesa Laboratories President, CEO Gary Owens Stepping Down, Effective April 12; Siddhartha Kadia Appointed Successor

Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB)

As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense

Mesa Laboratories, Inc.'s (NASDAQ:MLAB) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?

Wells Fargo Maintains Equal-Weight on Mesa Laboratories, Raises Price Target to $94

Mesa Laboratories shares are trading higher after the company reported better-than-expected Q3 sales results.

Mesa Laboratories shares are trading higher after the company reported better-than-expected Q3 sales results.

Mesa Labs: Fiscal Q3 Earnings Snapshot

Mesa Labs Announces Third Quarter Results

Mesa Laboratories Earnings Review: Q3 Summary

Mesa Laboratories Q3 Earnings Report: What Investors Need to Know

Mesa Laboratories Earnings Report: Q3 Overview

Insights into Mesa Laboratories Q3 Earnings

Earnings Breakdown: Mesa Laboratories Q3

Mesa Laboratories Q3 Earnings Assessment

Mesa Laboratories Q3 Adj. EPS $3.07, Sales $65.126M Beat $63.359M Estimate

Mesa Laboratories Q3 Earnings Summary & Key Takeaways